Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 14 | $7,125,178 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 05 Dec 2023 16:21 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 01 Dec 2023 | Sale | 24,000 | 61.135 | 1,467,240 | I |
| 21 Nov 2023 16:36 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 17 Nov 2023 | Sale | 8,894 | 49.991 | 444,620 | D |
| 21 Nov 2023 16:00 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 17 Oct 2023 | Sale | 24,000 | 49 | 1,176,000 | I |
| 17 Sep 2024 17:21 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 16 Sep 2024 | Sale | 7,524 | 36.79 | 276,808 | I |
| 17 Sep 2024 17:21 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 16 Sep 2024 | Sale | 29,476 | 36.09 | 1,063,789 | I |
| 21 Jun 2024 19:34 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 21 Jun 2024 | Sale | 1,695 | 39.63 | 67,173 | I |
| 21 Jun 2024 19:34 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 21 Jun 2024 | Sale | 35,305 | 39.22 | 1,384,662 | I |
| 20 Mar 2024 17:18 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 19 Mar 2024 | Sale | 18,681 | 57.179 | 1,068,161 | I |
| 05 Apr 2023 16:54 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 03 Apr 2023 | Sale | 500 | 74.05 | 37,025 | D |
| 02 Mar 2023 16:20 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 01 Mar 2023 | Sale | 500 | 65.33 | 32,665 | D |
| 02 Feb 2023 16:15 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 01 Feb 2023 | Sale | 500 | 52.61 | 26,305 | D |
| 05 Jan 2023 19:40 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 03 Jan 2023 | Sale | 500 | 50.7 | 25,350 | D |
| 02 Dec 2022 16:30 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 01 Dec 2022 | Sale | 500 | 49.93 | 24,965 | D |
| 03 Nov 2022 16:28 | APLS | Apellis Pharmaceuticals Inc | DUNLOP A. SINCLAIR | Director | 01 Nov 2022 | Sale | 500 | 60.83 | 30,415 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)